Annual Long Term Debt
$71.22 M
-$5.45 M-7.11%
December 31, 2023
Summary
- As of February 7, 2025, ABCL annual long term debt is $71.22 million, with the most recent change of -$5.45 million (-7.11%) on December 31, 2023.
- During the last 3 years, ABCL annual long term debt has risen by +$67.51 million (+1817.15%).
- ABCL annual long term debt is now -7.11% below its all-time high of $76.67 million, reached on December 31, 2022.
Performance
ABCL Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Debt
$66.27 M
-$177.00 K-0.27%
September 30, 2024
Summary
- As of February 7, 2025, ABCL quarterly long term debt is $66.27 million, with the most recent change of -$177.00 thousand (-0.27%) on September 30, 2024.
- Over the past year, ABCL quarterly long term debt has dropped by -$177.00 thousand (-0.27%).
- ABCL quarterly long term debt is now -15.12% below its all-time high of $78.08 million, reached on June 30, 2023.
Performance
ABCL Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
ABCL Long Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -7.1% | -0.3% |
| 3 y3 years | +1817.2% | +143.1% |
| 5 y5 years | +7716.3% | +1554.8% |
ABCL Long Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -7.1% | +95.6% | -15.1% | +102.3% |
| 5 y | 5-year | -7.1% | +1817.2% | -15.1% | +1684.0% |
| alltime | all time | -7.1% | +7716.3% | -15.1% | +1684.0% |
AbCellera Biologics Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $66.27 M(-0.3%) |
| Jun 2024 | - | $66.45 M(-2.4%) |
| Mar 2024 | - | $68.08 M(-4.4%) |
| Dec 2023 | $71.22 M(-7.1%) | $71.22 M(-5.3%) |
| Sep 2023 | - | $75.19 M(-3.7%) |
| Jun 2023 | - | $78.08 M(+1.1%) |
| Mar 2023 | - | $77.27 M(+0.8%) |
| Dec 2022 | $76.67 M | $76.67 M(+7.1%) |
| Sep 2022 | - | $71.59 M(+118.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $32.76 M(-9.9%) |
| Mar 2022 | - | $36.36 M(-0.2%) |
| Dec 2021 | $36.41 M(+880.2%) | $36.41 M(+33.6%) |
| Sep 2021 | - | $27.26 M(-12.1%) |
| Jun 2021 | - | $31.02 M(+82.8%) |
| Mar 2021 | - | $16.97 M(+356.9%) |
| Dec 2020 | $3.71 M(-7.2%) | $3.71 M(-25.8%) |
| Sep 2020 | - | $5.01 M(+25.0%) |
| Dec 2019 | $4.00 M(+339.5%) | $4.00 M |
| Dec 2018 | $911.20 K | - |
FAQ
- What is AbCellera Biologics annual long term debt?
- What is the all time high annual long term debt for AbCellera Biologics?
- What is AbCellera Biologics annual long term debt year-on-year change?
- What is AbCellera Biologics quarterly long term debt?
- What is the all time high quarterly long term debt for AbCellera Biologics?
- What is AbCellera Biologics quarterly long term debt year-on-year change?
What is AbCellera Biologics annual long term debt?
The current annual long term debt of ABCL is $71.22 M
What is the all time high annual long term debt for AbCellera Biologics?
AbCellera Biologics all-time high annual long term debt is $76.67 M
What is AbCellera Biologics annual long term debt year-on-year change?
Over the past year, ABCL annual long term debt has changed by -$5.45 M (-7.11%)
What is AbCellera Biologics quarterly long term debt?
The current quarterly long term debt of ABCL is $66.27 M
What is the all time high quarterly long term debt for AbCellera Biologics?
AbCellera Biologics all-time high quarterly long term debt is $78.08 M
What is AbCellera Biologics quarterly long term debt year-on-year change?
Over the past year, ABCL quarterly long term debt has changed by -$177.00 K (-0.27%)